Drug Delivery

Lipids for Self-Emulsifying Drug Delivery Systems

November 02, 2021

SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.

US Leads the Way for Drug Device Innovation but Lags Behind for Sustainability, Notes Pharmapack 2021 Report

September 24, 2021

The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.

BioMed X and Janssen Start Up Research Programs in Autoimmunity and Drug Delivery

August 26, 2021

BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

August 04, 2021

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Janssen Collaborates with BioMedX in Autoimmunity and Drug Delivery Research

August 04, 2021

BioMed X Institute and Janssen Research & Development to start two new research programs in the field of autoimmune diseases and drug delivery.

In-Vivo Demonstration of Enhanced Bioavailability of Acalabrutinib ASD Tablets

August 03, 2021

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

July 12, 2021

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

Pharmapack Innovation Index Reveals Continuing Innovation in Drug Delivery Across Europe

June 30, 2021

Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

June 16, 2021

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Aptamer and PinotBio Collaborate on Drug Conjugates for Targeted Drug Delivery

June 03, 2021

Aptamer Group and PinotBio have formed a strategic collaboration aimed at the development of new drug conjugates for targeted drug delivery.